<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="308319">
  <stage>Registered</stage>
  <submitdate>31/07/2009</submitdate>
  <approvaldate>6/08/2009</approvaldate>
  <actrnumber>ACTRN12609000671268</actrnumber>
  <trial_identification>
    <studytitle>Dysphagia in Inflammatory Muscle Diseases: Answering the Questions Who, Where, Why and What to Do?</studytitle>
    <scientifictitle>Dysphagia in Inflammatory Muscle Diseases: Answering the Questions Who, Where, Why and What to Do?</scientifictitle>
    <utrn />
    <trialacronym />
  </trial_identification>
  <conditions>
    <healthcondition>Swallowing (dysphagia) problems in patients with Inflammatory muscle diseases (Inclusion body myositis, dermatomyositis and polymyositis</healthcondition>
    <conditioncode>
      <conditioncode1>Musculoskeletal</conditioncode1>
      <conditioncode2>Other muscular and skeletal disorders</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>using videofluoroscopy and manometry to investigate the mechanisms behind swallowing problems reported by patients with inflammatory muscle diseases
Videofluoroscopy is a procedure where patients ingest radioopaque barium sulphaate mixed with small amounts of food/fluids.  The procedure is x-rayed using a fluoroscope and recorded to allow frame-by-frame analysis of the swallowing dynamic.  The procedure exposes patients to small amounts of ionising radiation (calculated as 0.2 milliseiverts).  
The Videofluoroscopy will be performed simulataneously with a manometric examination of the swallow.
Participants have a purpose built manometric catheter (outside diameter 2.0 mm) inserted via the nares and positioned in the upper oesophageal sphincter.  Recordings of upper oesophageal sphincter, oesophageal and pharyngeal pressures will be recorded.
TOTAL time for both procedures =30 minutes approx.</interventions>
    <comparator>N/A</comparator>
    <control>Uncontrolled</control>
    <interventioncode>Not applicable</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>determination of mechanism causing dysphagia in patients with inflammatory muscle diseases

Patients with inflammatory muscle diseases demonstrate food boluses pooling in the pharynx: this is often treated via cricopharyngeal myotomy.  There are 3 possible causes of this pooling: 1. poor pharyngeal muscle contraction 2. failure of the tonically contracted upper oesophageal sphincter to relax 3. impaired hyolaryngeal excursion.
Use of manometry in combination with videofluoroscopy will allow identification of which of the three mechanisms is impaired in the inflammatory muscle disease population.</outcome>
      <timepoint>The participants are required to undergo assessment one time only.  The time estimated that the study will take to complete is 6-12 months</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>N/A</outcome>
      <timepoint>N/A</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>diagnosed with inflammatory muscle diseases
able to provide informed consent
no surgical interventions to head/neck</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>90</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>unable to provide consent
surgical intervention to head/neck
any other neurological condition</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Observational</studytype>
    <purpose />
    <allocation />
    <concealment />
    <sequence />
    <masking />
    <assignment />
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs>Natural history</purposeobs>
    <duration>Cross-sectional</duration>
    <selection>Defined population</selection>
    <timing>Prospective</timing>
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate>1/08/2009</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>70</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Recruiting</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>Hospital</primarysponsortype>
    <primarysponsorname>Sir Charles Gairdner Hospital</primarysponsorname>
    <primarysponsoraddress>Hospital Avenue
Nedlands 6009
West Australia</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Hospital</fundingtype>
      <fundingname>Sir Charles Gairdner Hospital</fundingname>
      <fundingaddress>Hospital Avenue
Nedlands 6009
West Australia</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
    <othercollaborator>
      <othercollaboratortype>Other Collaborative groups</othercollaboratortype>
      <othercollaboratorname>Australian Neuromuscular Research Institute</othercollaboratorname>
      <othercollaboratoraddress>Hospital Avenue
Nedlands 6009
West Australia</othercollaboratoraddress>
      <othercollaboratorcountry>Australia</othercollaboratorcountry>
    </othercollaborator>
  </sponsorship>
  <ethicsAndSummary>
    <summary>This study aims to better investigate the underlying problem behind the swallowing difficulties (dysphagia) experienced by many people diagnosed with inflammatory muscle disorders (Inclusion Body Myositis, Dermatomyositis and Polymyositis)</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Not yet submitted</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Sir Charles Gairdner Hospital</ethicname>
      <ethicaddress>Hospital Avenue
Nedlands 6009
West Australia</ethicaddress>
      <ethicapprovaldate />
      <hrec>2009-060</hrec>
      <ethicsubmitdate>1/08/2009</ethicsubmitdate>
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Dr. Claire Langdon</name>
      <address>Sir Charles Gairdner Hospital
Hospital Avenue
Nedlands 6009
West Australia</address>
      <phone>+61-8-9346-2044</phone>
      <fax>+61-8-9346-4103</fax>
      <email>Claire.Langdon@health.wa.gov.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Dr. Claire Langdon</name>
      <address>Sir Charles Gairdner Hospital
Hospital Avenue
Nedlands 6009
West Australia</address>
      <phone>+61-8-9346-2044</phone>
      <fax>+61-8-9346-4103</fax>
      <email>Claire.Langdon@health.wa.gov.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name>Dr. Claire Langdon</name>
      <address>Sir Charles Gairdner Hospital
Hospital Avenue
Nedlands 6009
West Australia</address>
      <phone>+61-8-9346-2044</phone>
      <fax>+61-8-9346-4103</fax>
      <email>Claire.Langdon@health.wa.gov.au</email>
      <country>Australia</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>